D.J. St. Germain’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.01M | Sell |
17,453
-2,393
| -12% | -$137K | 0.04% | 174 |
|
|
2026
Q1 | $1.2M | Buy |
19,846
+200
| +1% | +$11.7K | 0.05% | 159 |
|
|
2025
Q4 | $1.06M | Sell |
19,646
-750
| -4% | -$36.1K | 0.04% | 167 |
|
|
2025
Q3 | $920K | Sell |
20,396
-1,162
| -5% | -$54.3K | 0.04% | 169 |
|
|
2025
Q2 | $998K | Buy |
21,558
+1,303
| +6% | +$64K | 0.04% | 165 |
|
|
2025
Q1 | $1.24M | Buy |
20,255
+110
| +0.5% | +$6.41K | 0.06% | 150 |
|
|
2024
Q4 | $1.14M | Sell |
20,145
-2,601
| -11% | -$145K | 0.05% | 163 |
|
|
2024
Q3 | $1.18M | Buy |
22,746
+1,021
| +5% | +$47.9K | 0.05% | 160 |
|
|
2024
Q2 | $902K | Sell |
21,725
-1,122
| -5% | -$50.2K | 0.04% | 165 |
|
|
2024
Q1 | $1.24M | Sell |
22,847
-91
| -0.4% | -$4.64K | 0.06% | 148 |
|
|
2023
Q4 | $1.18M | Buy |
22,938
+168
| +0.7% | +$8.82K | 0.06% | 145 |
|
|
2023
Q3 | $1.32M | Hold |
22,770
| – | – | 0.07% | 135 |
|
|
2023
Q2 | $1.46M | Buy |
+22,770
| New | +$1.53M | 0.08% | 130 |
|
|
2022
Q4 | $907K | Buy |
34,213
+11,535
| +51% | +$870K | 0.3% | 50 |
|
|
2022
Q3 | $1.75M | Hold |
22,678
| – | – | 0.12% | 103 |
|
|
2022
Q2 | $1.75M | Sell |
22,678
-215
| -0.9% | -$16.4K | 0.12% | 103 |
|
|
2022
Q1 | $1.67M | Sell |
22,893
-350
| -2% | -$23.5K | 0.09% | 109 |
|
|
2021
Q4 | $1.45M | Buy |
23,243
+426
| +2% | +$25K | 0.08% | 120 |
|
|
2021
Q3 | $1.35M | Buy |
22,817
+112
| +0.5% | +$7.38K | 0.08% | 111 |
|
|
2021
Q2 | $1.52M | Buy |
22,705
+114
| +0.5% | +$7.43K | 0.1% | 109 |
|
|
2021
Q1 | $1.43M | Buy |
22,591
+10
| +0% | +$622 | 0.1% | 103 |
|
|
2020
Q4 | $1.4M | Buy |
22,581
+1,972
| +10% | +$121K | 0.1% | 103 |
|
|
2020
Q3 | $1.24M | Sell |
20,609
-311
| -1% | -$18.7K | 0.1% | 100 |
|
|
2020
Q2 | $1.23M | Sell |
20,920
-1,115
| -5% | -$66.7K | 0.11% | 101 |
|
|
2020
Q1 | $1.23M | Buy |
22,035
+1,121
| +5% | +$68.5K | 0.12% | 96 |
|
|
2019
Q4 | $1.34M | Buy |
20,914
+12,415
| +146% | +$711K | 0.11% | 106 |
|
|
2019
Q3 | $431K | Buy |
8,499
+86
| +1% | +$4.04K | 0.05% | 127 |
|
|
2019
Q2 | $382K | Hold |
8,413
| – | – | 0.04% | 133 |
|
|
2019
Q1 | $401K | Sell |
8,413
-250
| -3% | -$12.5K | 0.04% | 133 |
|
|
2018
Q4 | $450K | Buy |
8,663
+2,180
| +34% | +$117K | 0.05% | 119 |
|
|
2018
Q3 | $402K | Buy |
+6,483
| New | +$385K | 0.05% | 127 |
|
Other funds holding BMY
D.J. St. Germain's BMY Position: Q2 2026 in Review
D.J. St. Germain reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, selling an estimated $137K and leaving 17,453 shares worth $1.01M. The position accounts for 0.04% of the portfolio, ranked #174.
D.J. St. Germain first reported a position in BMY in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.75M in Q3 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- D.J. St. Germain held 17,453 shares of Bristol-Myers Squibb worth $1.01M as of Q2 2026.
- D.J. St. Germain sold 2,393 Bristol-Myers Squibb shares in Q2 2026, an estimated $137K.
- Bristol-Myers Squibb made up 0.04% of D.J. St. Germain's portfolio in Q2 2026, its #174 holding.
- D.J. St. Germain first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 31 quarters since.
- D.J. St. Germain's Bristol-Myers Squibb position peaked at $1.75M in Q3 2022.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.